Form 4: Avanos Medical Director Lisa Egbuonu-Davis Acquires 12,003 Shares Through Restricted Stock Units

Director Lisa Egbuonu-Davis acquired 12,003 shares of Avanos Medical, Inc. through restricted stock units on January 2, 2025.

Summary

• Lisa Egbuonu-Davis, a director at Avanos Medical, Inc., acquired 12,003 shares of common stock.
• The acquisition was made through restricted stock units (RSUs) granted under the company's Outside Directors' Compensation Plan.
• The transaction occurred on January 2, 2025.
• Following the transaction, Ms. Egbuonu-Davis beneficially owns 25,814 shares of Avanos Medical, Inc.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to slightly positive as it aligns director interests with shareholders.

Positives

• The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.

Industry Context

This is a routine filing related to director compensation and is common practice for publicly traded companies.

Comparison to Industry Standards

• The granting of restricted stock units to directors is a common practice in publicly traded companies as part of their compensation packages.
• The number of shares granted is within the typical range for director compensation at similar companies.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with the company's performance.

Key Dates

Keywords

Avanos Medical, Director, Lisa Egbuonu-Davis, Restricted Stock Units, RSU, Share Acquisition, Insider Trading, Beneficial Ownership